TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs62529502
log Bayes Factor = 0.0806811
Chromosome 9   position 9,142,493  (GRCh37) Explore rs62529502 on Ensembl!
Variant rs62529502 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T39.1 4-Aminophenol derivatives
0.000 0.888 0.112
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.890 0.110
T40.2 Other opioids
0.000 0.898 0.102
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.900 0.100
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.900 0.100
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.901 0.099
T39.0 Salicylates
0.000 0.903 0.097
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.914 0.086
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.921 0.079
T39.4 Antirheumatics, not elsewhere classified
0.000 0.921 0.079
T39.2 Pyrazolone derivatives
0.000 0.921 0.079
T42.4 Benzodiazepines
0.000 0.922 0.078
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.925 0.075
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.927 0.072
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.928 0.072
T40.8 Lysergide [LSD]
0.000 0.928 0.072
T40.7 Cannabis (derivatives)
0.000 0.928 0.072
T40.5 Cocaine
0.000 0.928 0.072
T40.4 Other synthetic narcotics
0.000 0.928 0.072
T40.3 Methadone
0.000 0.928 0.072
T40.1 Heroin
0.000 0.928 0.072
T40.0 Opium
0.000 0.928 0.072
T36 Poisoning by systemic antibiotics
0.000 0.928 0.072
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.928 0.072
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.928 0.072
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.928 0.072
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.928 0.072
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.928 0.072
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.929 0.071
C77.2 Intra-abdominal lymph nodes
0.070 0.930 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.931 0.069
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.931 0.069
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.931 0.069
T40.6 Other and unspecified narcotics
0.000 0.932 0.068
T43.2 Other and unspecified antidepressants
0.000 0.934 0.066
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.937 0.062
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.938 0.062
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.938 0.062
T42.3 Barbiturates
0.000 0.938 0.062
T42.2 Succinimides and oxazolidinediones
0.000 0.938 0.062
T42.0 Hydantoin derivatives
0.000 0.938 0.062
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.938 0.061
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.939 0.061
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.944 0.056
T42.1 Iminostilbenes
0.000 0.945 0.055
T46.1 Calcium-channel blockers
0.000 0.948 0.052
T43.9 Psychotropic drug, unspecified
0.000 0.948 0.052
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.948 0.052
T43.6 Psychostimulants with abuse potential
0.000 0.948 0.052
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.948 0.052
T36.0 Penicillins
0.000 0.948 0.052
T36.9 Systemic antibiotic, unspecified
0.000 0.948 0.051
T36.8 Other systemic antibiotics
0.000 0.948 0.051
T36.7 Antifungal antibiotics, systemically used
0.000 0.948 0.051
T36.6 Rifamycins
0.000 0.948 0.051
T36.5 Aminoglycosides
0.000 0.948 0.051
T36.4 Tetracyclines
0.000 0.948 0.051
T36.3 Macrolides
0.000 0.948 0.051
T36.2 Chloramphenicol group
0.000 0.948 0.051
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.948 0.051
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.948 0.051
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.948 0.051
T37.5 Antiviral drugs
0.000 0.948 0.051
T37.4 Anthelminthics
0.000 0.948 0.051
T37.3 Other antiprotozoal drugs
0.000 0.948 0.051
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.948 0.051
T37.1 Antimycobacterial drugs
0.000 0.948 0.051
T37.0 Sulphonamides
0.000 0.948 0.051
T41.5 Therapeutic gases
0.000 0.948 0.051
T41.4 Anaesthetic, unspecified
0.000 0.948 0.051
T41.3 Local anaesthetics
0.000 0.948 0.051
T41.2 Other and unspecified general anaesthetics
0.000 0.948 0.051
T41.1 Intravenous anaesthetics
0.000 0.948 0.051
T41.0 Inhaled anaesthetics
0.000 0.948 0.051
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.948 0.051
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.948 0.051
T47.7 Emetics
0.000 0.948 0.051
T47.6 Antidiarrhoeal drugs
0.000 0.948 0.051
T47.5 Digestants
0.000 0.948 0.051
T47.4 Other laxatives
0.000 0.948 0.051
T47.3 Saline and osmotic laxatives
0.000 0.948 0.051
T47.2 Stimulant laxatives
0.000 0.948 0.051
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.948 0.051
T47.0 Histamine H(2)-receptor antagonists
0.000 0.948 0.051
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.948 0.051
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.948 0.051
T48.5 Anti-common-cold drugs
0.000 0.948 0.051
T48.4 Expectorants
0.000 0.948 0.051
T48.3 Antitussives
0.000 0.948 0.051
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.948 0.051
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.948 0.051
T48.0 Oxytocic drugs
0.000 0.948 0.051
T49.9 Topical agent, unspecified
0.000 0.948 0.051
T49.8 Other topical agents
0.000 0.948 0.051
T49.7 Dental drugs, topically applied
0.000 0.948 0.051
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.948 0.051
T49.5 Ophthalmological drugs and preparations
0.000 0.948 0.051
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.948 0.051
T49.3 Emollients, demulcents and protectants
0.000 0.948 0.051
T49.2 Local astringents and local detergents
0.000 0.948 0.051
T49.1 Antipruritics
0.000 0.948 0.051
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.948 0.051
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.949 0.051
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.949 0.051
T46.7 Peripheral vasodilators
0.000 0.949 0.051
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.949 0.051
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.949 0.051
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.949 0.051
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.949 0.051
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.949 0.051
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.949 0.051
T45.0 Antiallergic and antiemetic drugs
0.000 0.950 0.050
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.950 0.050
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.950 0.050
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.950 0.050
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.950 0.050
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.950 0.050
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.950 0.050
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.950 0.050
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.950 0.050
T44.0 Anticholinesterase agents
0.000 0.950 0.050
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.950 0.050
T45.8 Other primarily systemic and haematological agents
0.000 0.950 0.050
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.950 0.050
T45.6 Fibrinolysis-affecting drugs
0.000 0.950 0.050
T45.4 Iron and its compounds
0.000 0.950 0.050
T45.3 Enzymes, not elsewhere classified
0.000 0.950 0.050
T45.2 Vitamins, not elsewhere classified
0.000 0.950 0.050
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.950 0.050
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.952 0.048
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.952 0.047
T45.5 Anticoagulants
0.000 0.953 0.047
T50.8 Diagnostic agents
0.000 0.955 0.045
T50.7 Analeptics and opioid receptor antagonists
0.000 0.955 0.045
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.955 0.045
T50.5 Appetite depressants
0.000 0.955 0.045
T50.4 Drugs affecting uric acid metabolism
0.000 0.955 0.045
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.955 0.045
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.955 0.045
T50.1 Loop [high-ceiling] diuretics
0.000 0.955 0.045
T50.0 Mineralocorticoids and their antagonists
0.000 0.955 0.045
T38.9 Other and unspecified hormone antagonists
0.000 0.956 0.044
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.956 0.044
T38.7 Androgens and anabolic congeners
0.000 0.956 0.044
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.956 0.044
T38.5 Other oestrogens and progestogens
0.000 0.956 0.044
T38.4 Oral contraceptives
0.000 0.956 0.044
T38.2 Antithyroid drugs
0.000 0.956 0.044
T38.1 Thyroid hormones and substitutes
0.000 0.956 0.044
T38.0 Glucocorticoids and synthetic analogues
0.000 0.956 0.044
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.964 0.036
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.967 0.033
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.967 0.032
K52.9 Non-infective gastro-enteritis and colitis, unspecified
0.031 0.969 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.970 0.029
K52 Other non-infective gastro-enteritis and colitis
0.023 0.977 0.000
K52.8 Other specified non-infective gastro-enteritis and colitis
0.022 0.978 0.000
K52.2 Allergic and dietetic gastro-enteritis and colitis
0.018 0.982 0.000
J38.7 Other diseases of larynx
0.000 0.982 0.018
D69.6 Thrombocytopenia, unspecified
0.017 0.983 0.000
D69 Purpura and other haemorrhagic conditions
0.017 0.983 0.000
K52.3 Indeterminate colitis
0.017 0.983 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.017 0.983 0.000
J38.3 Other diseases of vocal cords
0.000 0.984 0.016
K52.0 Gastro-enteritis and colitis due to radiation
0.016 0.984 0.000
E10 Insulin-dependent diabetes mellitus
0.016 0.984 0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified
0.000 0.984 0.016
E11 Non-insulin-dependent diabetes mellitus
0.015 0.985 0.000
E10-E14 Diabetes mellitus
0.015 0.985 0.000
E10.1 With ketoacidosis
0.015 0.985 0.000
E11.3 With ophthalmic complications
0.015 0.985 0.000
K52.1 Toxic gastro-enteritis and colitis
0.014 0.985 0.000
E10.5 With peripheral circulatory complications
0.014 0.986 0.000
E11.1 With ketoacidosis
0.014 0.986 0.000
E14 Unspecified diabetes mellitus
0.014 0.986 0.000
E10.2 With renal complications
0.014 0.986 0.000
D69.0 Allergic purpura
0.014 0.986 0.000
E10.6 With other specified complications
0.013 0.987 0.000
E14.3 With ophthalmic complications
0.013 0.987 0.000
J38.0 Paralysis of vocal cords and larynx
0.000 0.987 0.013
D69.5 Secondary thrombocytopenia
0.013 0.987 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.013 0.987 0.000
E11.4 With neurological complications
0.013 0.987 0.000
D69.9 Haemorrhagic condition, unspecified
0.012 0.988 0.000
D69.8 Other specified haemorrhagic conditions
0.012 0.988 0.000
D69.4 Other primary thrombocytopenia
0.012 0.988 0.000
D69.2 Other nonthrombocytopenic purpura
0.012 0.988 0.000
D69.1 Qualitative platelet defects
0.012 0.988 0.000
J38.1 Polyp of vocal cord and larynx
0.000 0.988 0.012
E10.8 With unspecified complications
0.012 0.988 0.000
E11.6 With other specified complications
0.012 0.988 0.000
E10.7 With multiple complications
0.012 0.988 0.000
E10.0 With coma
0.012 0.988 0.000
J38.5 Laryngeal spasm
0.000 0.988 0.011
E11.8 With unspecified complications
0.011 0.989 0.000
J38.4 Oedema of larynx
0.000 0.989 0.011
E14.9 Without complications
0.011 0.989 0.000
E11.7 With multiple complications
0.011 0.989 0.000
E11.0 With coma
0.011 0.989 0.000
E12 Malnutrition-related diabetes mellitus
0.011 0.989 0.000
E10.4 With neurological complications
0.011 0.989 0.000
E11.5 With peripheral circulatory complications
0.011 0.989 0.000
K66.0 Peritoneal adhesions
0.011 0.989 0.000
E10.3 With ophthalmic complications
0.010 0.989 0.000
J38.2 Nodules of vocal cords
0.000 0.989 0.010
J38.6 Stenosis of larynx
0.000 0.989 0.010
E11.2 With renal complications
0.010 0.990 0.000
E14.8 With unspecified complications
0.010 0.990 0.000
E14.7 With multiple complications
0.010 0.990 0.000
E14.6 With other specified complications
0.010 0.990 0.000
E14.5 With peripheral circulatory complications
0.010 0.990 0.000
E14.4 With neurological complications
0.010 0.990 0.000
E14.2 Withrenal complications
0.010 0.990 0.000
E14.1 With ketoacidosis
0.010 0.990 0.000
E14.0 With coma
0.010 0.990 0.000
E10.9 Without complications
0.010 0.990 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.010 0.990 0.000
D66 Hereditary factor VIII deficiency
0.010 0.990 0.000
E13 Other specified diabetes mellitus
0.010 0.990 0.000
D67 Hereditary factor IX deficiency
0.009 0.991 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.009 0.991 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.009 0.991 0.000
R26.8 Other and unspecified abnormalities of gait and mobility
0.009 0.991 0.000
D50-D53 Nutritional anaemias
0.009 0.991 0.000
D55-D59 Haemolytic anaemias
0.009 0.991 0.000
D75 Other diseases of blood and blood-forming organs
0.009 0.991 0.000
D51 Vitamin B12 deficiency anaemia
0.008 0.992 0.000
D59 Acquired haemolytic anaemia
0.008 0.992 0.000
E12.9 Without complications
0.008 0.992 0.000
E12.8 With unspecified complications
0.008 0.992 0.000
E12.7 With multiple complications
0.008 0.992 0.000
E12.6 With other specified complications
0.008 0.992 0.000
E12.5 With peripheral circulatory complications
0.008 0.992 0.000
E12.4 With neurological complications
0.008 0.992 0.000
E12.3 With ophthalmic complications
0.008 0.992 0.000
E12.2 With renal complications
0.008 0.992 0.000
E12.1 With ketoacidosis
0.008 0.992 0.000
E12.0 With coma
0.008 0.992 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.008 0.992 0.000
D75.2 Essential thrombocytosis
0.008 0.992 0.000
D59.1 Other autoimmune haemolytic anaemias
0.008 0.992 0.000
D68 Other coagulation defects
0.008 0.992 0.000
R63.4 Abnormal weight loss
0.007 0.993 0.000
D75.9 Disease of blood and blood-forming organs, unspecified
0.007 0.993 0.000
D76.3 Other histiocytosis syndromes
0.007 0.993 0.000
D80-D89 Certain disorders involving the immune mechanism
0.007 0.993 0.000
E13.8 With unspecified complications
0.007 0.993 0.000
E13.7 With multiple complications
0.007 0.993 0.000
E13.6 With other specified complications
0.007 0.993 0.000
E13.5 With peripheral circulatory complications
0.007 0.993 0.000
E13.4 With neurological complications
0.007 0.993 0.000
E13.3 With ophthalmic complications
0.007 0.993 0.000
E13.2 With renal complications
0.007 0.993 0.000
E13.1 With ketoacidosis
0.007 0.993 0.000
E13.0 With coma
0.007 0.993 0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified
0.007 0.993 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.007 0.993 0.000
R26 Abnormalities of gait and mobility
0.007 0.993 0.000
R26.3 Immobility
0.007 0.993 0.000
D50 Iron deficiency anaemia
0.007 0.993 0.000
D74 Methaemoglobinaemia
0.007 0.993 0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.007 0.993 0.000
D71 Functional disorders of polymorphonuclear neutrophils
0.007 0.993 0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.007 0.993 0.000
D73 Diseases of spleen
0.007 0.993 0.000
D52 Folate deficiency anaemia
0.007 0.993 0.000
D53 Other nutritional anaemias
0.007 0.993 0.000
D58 Other hereditary haemolytic anaemias
0.007 0.993 0.000
R04.0 Epistaxis
0.007 0.993 0.000
D57 Sickle-cell disorders
0.006 0.993 0.000
D56 Thalassaemia
0.006 0.993 0.000
D55 Anaemia due to enzyme disorders
0.006 0.993 0.000
D75.1 Secondary polycythaemia
0.007 0.993 0.000
D75.0 Familial erythrocytosis
0.006 0.993 0.000
D72 Other disorders of white blood cells
0.006 0.994 0.000
D68.6 Other Thrombophilia
0.006 0.994 0.000
D51.8 Other vitamin B12 deficiency anaemias
0.006 0.994 0.000
D51.3 Other dietary vitamin B12 deficiency anaemia
0.006 0.994 0.000
D51.2 Transcobalamin II deficiency
0.006 0.994 0.000
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
0.006 0.994 0.000
D59.9 Acquired haemolytic anaemia, unspecified
0.006 0.994 0.000
D59.8 Other acquired haemolytic anaemias
0.006 0.994 0.000
D59.6 Haemoglobinuria due to haemolysis from other external causes
0.006 0.994 0.000
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
0.006 0.994 0.000
D59.4 Other nonautoimmune haemolytic anaemias
0.006 0.994 0.000
D59.3 Haemolytic-uraemic syndrome
0.006 0.994 0.000
D59.2 Drug-induced nonautoimmune haemolytic anaemia
0.006 0.994 0.000
D59.0 Drug-induced autoimmune haemolytic anaemia
0.006 0.994 0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.006 0.994 0.000
D68.8 Other specified coagulation defects
0.006 0.994 0.000
D76.2 Haemophagocytic syndrome, infection-associated
0.006 0.994 0.000
D76.1 Haemophagocytic lymphohistiocytosis
0.006 0.994 0.000
D76.0 Langerhans' cell histiocytosis, not elsewhere classified
0.006 0.994 0.000
D68.0 Von Willebrand's disease
0.006 0.994 0.000
D75.8 Other specified diseases of blood and blood-forming organs
0.006 0.994 0.000
E13.9 Without complications
0.006 0.994 0.000
D73.8 Other diseases of spleen
0.006 0.994 0.000
D70 Agranulocytosis
0.006 0.994 0.000
C77.8 Lymph nodes of multiple regions
0.006 0.994 0.000
D50.9 Iron deficiency anaemia, unspecified
0.006 0.994 0.000
D68.4 Acquired coagulation factor deficiency
0.006 0.994 0.000
D68.1 Hereditary factor XI deficiency
0.006 0.994 0.000
C77.4 Inguinal and lower limb lymph nodes
0.006 0.994 0.000
D50.8 Other iron deficiency anaemias
0.006 0.994 0.000
C77.5 Intrapelvic lymph nodes
0.006 0.994 0.000
K66 Other disorders of peritoneum
0.006 0.994 0.000
D84 Other immunodeficiencies
0.005 0.994 0.000
D83 Common variable immunodeficiency
0.005 0.994 0.000
D82 Immunodeficiency associated with other major defects
0.005 0.994 0.000
D81 Combined immunodeficiencies
0.005 0.994 0.000
R26.2 Difficulty in walking, not elsewhere classified
0.005 0.995 0.000
Z02.8 Other examinations for administrative purposes
0.005 0.995 0.000
R26.0 Ataxic gait
0.005 0.995 0.000
N86 Erosion and ectropion of cervix uteri
0.005 0.995 0.000
D68.5 Primary Thrombophilia
0.005 0.995 0.000
R26.1 Paralytic gait
0.005 0.995 0.000
D60-D64 Aplastic and other anaemias
0.005 0.995 0.000
D50.1 Sideropenic dysphagia
0.005 0.995 0.000
D74.9 Methaemoglobinaemia, unspecified
0.005 0.995 0.000
D74.8 Other methaemoglobinaemias
0.005 0.995 0.000
D74.0 Congenital methaemoglobinaemia
0.005 0.995 0.000
D86 Sarcoidosis
0.005 0.995 0.000
D73.9 Disease of spleen, unspecified
0.005 0.995 0.000
D73.4 Cyst of spleen
0.005 0.995 0.000
D73.3 Abscess of spleen
0.005 0.995 0.000
D73.2 Chronic congestive splenomegaly
0.005 0.995 0.000
D73.1 Hypersplenism
0.005 0.995 0.000
D52.9 Folate deficiency anaemia, unspecified
0.005 0.995 0.000
D52.8 Other folate deficiency anaemias
0.005 0.995 0.000
D52.1 Drug-induced folate deficiency anaemia
0.005 0.995 0.000
D52.0 Dietary folate deficiency anaemia
0.005 0.995 0.000
D53.9 Nutritional anaemia, unspecified
0.005 0.995 0.000
D53.8 Other specified nutritional anaemias
0.005 0.995 0.000
D53.2 Scorbutic anaemia
0.005 0.995 0.000
D53.1 Other megaloblastic anaemias, not elsewhere classified
0.005 0.995 0.000
D53.0 Protein deficiency anaemia
0.005 0.995 0.000
D89.9 Disorder involving the immune mechanism, unspecified
0.005 0.995 0.000
D58.9 Hereditary haemolytic anaemia, unspecified
0.005 0.995 0.000
D58.8 Other specified hereditary haemolytic anaemias
0.005 0.995 0.000
D58.2 Other haemoglobinopathies
0.005 0.995 0.000
D58.1 Hereditary elliptocytosis
0.005 0.995 0.000
D58.0 Hereditary spherocytosis
0.005 0.995 0.000
D55.9 Anaemia due to enzyme disorder, unspecified
0.005 0.995 0.000
D55.8 Other anaemias due to enzyme disorders
0.005 0.995 0.000
D55.3 Anaemia due to disorders of nucleotide metabolism
0.005 0.995 0.000
D55.2 Anaemia due to disorders of glycolytic enzymes
0.005 0.995 0.000
D55.1 Anaemia due to other disorders of glutathione metabolism
0.005 0.995 0.000
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
0.005 0.995 0.000
D56.9 Thalassaemia, unspecified
0.005 0.995 0.000
D56.8 Other thalassaemias
0.005 0.995 0.000
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]
0.005 0.995 0.000
D56.3 Thalassaemia trait
0.005 0.995 0.000
D56.2 Delta-beta thalassaemia
0.005 0.995 0.000
D56.1 Beta thalassaemia
0.005 0.995 0.000
D56.0 Alpha thalassaemia
0.005 0.995 0.000
D57.8 Other sickle-cell disorders
0.005 0.995 0.000
D57.3 Sickle-cell trait
0.005 0.995 0.000
D57.2 Double heterozygous sickling disorders
0.005 0.995 0.000
D57.1 Sickle-cell anaemia without crisis
0.005 0.995 0.000
D57.0 Sickle-cell anaemia with crisis
0.005 0.995 0.000
D68.2 Hereditary deficiency of other clotting factors
0.005 0.995 0.000
D68.9 Coagulation defect, unspecified
0.005 0.995 0.000
D89.2 Hypergammaglobulinaemia, unspecified
0.005 0.995 0.000
D61 Other aplastic anaemias
0.005 0.995 0.000
D72.9 Disorder of white blood cells, unspecified
0.005 0.995 0.000
D72.0 Genetic anomalies of leukocytes
0.005 0.995 0.000
D80 Immunodeficiency with predominantly antibody defects
0.004 0.995 0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.005 0.995 0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.004 0.995 0.000
D89.3 Immune reconstitution syndrome
0.004 0.995 0.000
D89.1 Cryoglobulinaemia
0.004 0.995 0.000
D89.0 Polyclonal hypergammaglobulinaemia
0.004 0.995 0.000
D73.5 Infarction of spleen
0.004 0.995 0.000
D86.3 Sarcoidosis of skin
0.004 0.995 0.000
D61.9 Aplastic anaemia, unspecified
0.005 0.995 0.000
D72.8 Other specified disorders of white blood cells
0.004 0.995 0.000
D73.0 Hyposplenism
0.004 0.996 0.000
D86.9 Sarcoidosis, unspecified
0.004 0.996 0.000
D72.1 Eosinophilia
0.004 0.996 0.000
K66.9 Disorder of peritoneum, unspecified
0.004 0.996 0.000
K66.8 Other specified disorders of peritoneum
0.004 0.996 0.000
K66.1 Haemoperitoneum
0.004 0.996 0.000
C77.3 Axillary and upper limb lymph nodes
0.004 0.996 0.000
D81.9 Combined immunodeficiency, unspecified
0.004 0.996 0.000
D81.8 Other combined immunodeficiencies
0.004 0.996 0.000
D81.7 Major histocompatibility complex class II deficiency
0.004 0.996 0.000
D81.6 Major histocompatibility complex class I deficiency
0.004 0.996 0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency
0.004 0.996 0.000
D81.4 Nezelof's syndrome
0.004 0.996 0.000
D81.3 Adenosine deaminase [ADA] deficiency
0.004 0.996 0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
0.004 0.996 0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
0.004 0.996 0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis
0.004 0.996 0.000
D82.9 Immunodeficiency associated with major defect, unspecified
0.004 0.996 0.000
D82.8 Immunodeficiency associated with other specified major defects
0.004 0.996 0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome
0.004 0.996 0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
0.004 0.996 0.000
D82.2 Immunodeficiency with short-limbed stature
0.004 0.996 0.000
D82.1 Di George's syndrome
0.004 0.996 0.000
D82.0 Wiskott-Aldrich syndrome
0.004 0.996 0.000
D83.9 Common variable immunodeficiency, unspecified
0.004 0.996 0.000
D83.8 Other common variable immunodeficiencies
0.004 0.996 0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
0.004 0.996 0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
0.004 0.996 0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
0.004 0.996 0.000
D84.9 Immunodeficiency, unspecified
0.004 0.996 0.000
D84.8 Other specified immunodeficiencies
0.004 0.996 0.000
D84.1 Defects in the complement system
0.004 0.996 0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
0.004 0.996 0.000
D60 Acquired pure red cell aplasia [erythroblastopenia]
0.004 0.996 0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.004 0.996 0.000
D86.1 Sarcoidosis of lymph nodes
0.004 0.996 0.000
Y84.2 Radiological procedure and radiotherapy
0.000 0.996 0.004
D61.8 Other specified aplastic anaemias
0.004 0.996 0.000
D61.3 Idiopathic aplastic anaemia
0.004 0.996 0.000
D61.2 Aplastic anaemia due to other external agents
0.004 0.996 0.000
D61.1 Drug-induced aplastic anaemia
0.004 0.996 0.000
D61.0 Constitutional aplastic anaemia
0.004 0.996 0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
0.003 0.996 0.000
D80.8 Other immunodeficiencies with predominantly antibody defects
0.003 0.996 0.000
D80.7 Transient hypogammaglobulinaemia of infancy
0.003 0.996 0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
0.003 0.996 0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
0.003 0.996 0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]
0.003 0.996 0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
0.003 0.996 0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]
0.003 0.996 0.000
D80.0 Hereditary hypogammaglobulinaemia
0.003 0.996 0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)
0.000 0.996 0.004
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)
0.003 0.996 0.000
D86.8 Sarcoidosis of other and combined sites
0.003 0.996 0.000
K50-K52 Noninfective enteritis and colitis
0.004 0.996 0.000
D64 Other anaemias
0.003 0.997 0.000
C77.9 Lymph node, unspecified
0.003 0.997 0.000
C77.0 Lymph nodes of head, face and neck
0.003 0.997 0.000
Z29.8 Other specified prophylactic measures
0.000 0.997 0.003
D60.9 Acquired pure red cell aplasia, unspecified
0.003 0.997 0.000
D60.8 Other acquired pure red cell aplasias
0.003 0.997 0.000
D60.1 Transient acquired pure red cell aplasia
0.003 0.997 0.000
D60.0 Chronic acquired pure red cell aplasia
0.003 0.997 0.000
D80.1 Nonfamilial hypogammaglobulinaemia
0.002 0.997 0.001
E83.4 Disorders of magnesium metabolism
0.003 0.997 0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress
0.003 0.997 0.000
D62 Acute posthaemorrhagic anaemia
0.003 0.997 0.000
T51.0 Ethanol
0.000 0.997 0.003
Y84.6 Urinary catheterisation
0.000 0.997 0.003
K40.2 Bilateral inguinal hernia, without obstruction or gangrene
0.003 0.997 0.000
Y60.0 During surgical operation
0.003 0.997 0.000
D64.4 Congenital dyserythropoietic anaemia
0.003 0.997 0.000
D64.3 Other sideroblastic anaemias
0.003 0.997 0.000
D64.2 Secondary sideroblastic anaemia due to drugs and toxins
0.003 0.997 0.000
D64.1 Secondary sideroblastic anaemia due to disease
0.003 0.997 0.000
D64.0 Hereditary sideroblastic anaemia
0.003 0.997 0.000
Z74.0 Reduced mobility
0.003 0.997 0.000
D86.0 Sarcoidosis of lung
0.002 0.997 0.000
Z29 Need for other prophylactic measures
0.000 0.997 0.003
Z29.0 Isolation
0.000 0.997 0.003
D64.8 Other specified anaemias
0.003 0.997 0.000
O20.0 Threatened abortion
0.000 0.997 0.003
D63 Anaemia in chronic diseases classified elsewhere
0.002 0.997 0.000
C77.1 Intrathoracic lymph nodes
0.003 0.997 0.000
F81.9 Developmental disorder of scholastic skills, unspecified
0.003 0.997 0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
Z29.1 Prophylactic immunotherapy
0.000 0.997 0.002
D23.5 Skin of trunk
0.000 0.998 0.002
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
0.002 0.998 0.000
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
0.000 0.998 0.002
M47.92 Spondylosis, unspecified (Cervical region)
0.002 0.998 0.000
E53.8 Deficiency of other specified B group vitamins
0.002 0.998 0.000
Z02 Examination and encounter for administrative purposes
0.002 0.998 0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident
0.002 0.998 0.000
E53 Deficiency of other B group vitamins
0.002 0.998 0.000
J32.0 Chronic maxillary sinusitis
0.002 0.998 0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.002 0.998 0.000
E50-E64 Other nutritional deficiencies
0.002 0.998 0.000
C80.9 Malignant neoplasm, unspecified
0.000 0.998 0.002
Z29.9 Prophylactic measure, unspecified
0.000 0.998 0.002
O26.8 Other specified pregnancy-related conditions
0.000 0.998 0.002
Z29.2 Other prophylactic chemotherapy
0.000 0.998 0.002
Z75.1 Person awaiting admission to adequate facility elsewhere
0.002 0.998 0.000
D63.1 Anaemia in other chronic diseases classified elsewhere
0.002 0.998 0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.002 0.998 0.000
O36.0 Maternal care for rhesus isoimmunisation
0.000 0.998 0.002
W49.9 Unspecified place
0.002 0.998 0.000
Y60.4 During endoscopic examination
0.002 0.998 0.000
Y95 Nosocomial condition
0.002 0.998 0.000
Y84.4 Aspiration of fluid
0.000 0.998 0.002
F20.9 Schizophrenia, unspecified
0.002 0.998 0.000
R04.8 Haemorrhage from other sites in respiratory passages
0.002 0.998 0.000
R04 Haemorrhage from respiratory passages
0.002 0.998 0.000
D64.9 Anaemia, unspecified
0.002 0.998 0.000
E83 Disorders of mineral metabolism
0.002 0.998 0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)
0.002 0.998 0.000
B37.3 Candidiasis of vulva and vagina
0.002 0.998 0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.002 0.998 0.000
E61 Deficiency of other nutrient elements
0.002 0.998 0.000
V18 Pedal cyclist injured in noncollision transport accident
0.002 0.998 0.000
K86.1 Other chronic pancreatitis
0.000 0.998 0.002
E87.7 Fluid overload
0.002 0.998 0.000
Y60.9 During unspecified surgical and medical care
0.002 0.998 0.000
Y60.8 During other surgical and medical care
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.